Your search returned 22 results.

Results
	21.	Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis. [electronic resource] by Bell, Christine Anderson, James Ganguly, Tanmoy Prescott, James Capila, Ishan Lansing, Jonathan C Sachleben, Richard Iyer, Mani Fier, Ian Roach, James Storey, Kristina Miller, Paul Hall, Steven Kantor, Daniel Greenberg, Benjamin M Nair, Kavita Glajch, Joseph Producer: 20190109 In: Journal of pharmacy practice vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	22.	Effectiveness of alternative dose fingolimod for multiple sclerosis. [electronic resource] by Longbrake, Erin E Kantor, Daniel Pawate, Siddharama Bradshaw, Michael J von Geldern, Gloria Chahin, Salim Cross, Anne H Parks, Becky J Rice, Marc Khoury, Samia J Yamout, Bassem Zeineddine, Maya Russell-Giller, Shira Caminero-Rodriguez, Ana Edwards, Keith Lathi, Ellen VanderKodde, Danita Meador, William Berkovich, Regina Ge, Lily Bacon, Tamar E Kister, Ilya Publication details: Neurology. Clinical practice Apr 2018 In: Neurology. Clinical practice vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search